LAUSR

The recent global pandemic has lead to a surge in biomedical publications (1), which came at a time when a rather intense discussion on quality control for research results was already ongoing. The scientific community had just seen a huge increase in predatory journals and conference offers (aka the kind of email invitations you delete on autopilot while having your first cup of tea in the morning), a situation which was apparently notably aggravated in early 2020. Undoubtedly, the need for information on Covid-19 from experts trying to keep on top of the latest results, political decision makers and the public in an age of immediately-available information was unprecedented and tipped the balance of supply and demand as it had not been before. Almost two years later, it may be time for a careful look at the effects of the pandemic on biomedical publishing.